Merck’s Vaccine Division President Julie Gerberding Sells $9.1 Million in Shares—Is She Jumping Ship?
By Robert F. Kennedy, Jr., CHD Chairman
SEC filings reveal that Merck’s Vaccine Division President Julie Gerberding sold over half her Merck shares in January for $9.1 Million. That transaction followed a spate of bad news for Merck’s flagship Gardasil vaccine.
It is still uncertain whether the human papillomavirus (HPV) vaccination prevents cervical cancer as trials were not designed to detect this outcome.
Last month, Cancer Research UK announced an alarming 54% rise in cervical cancer among 24-29-year-olds, the first generation to receive the HPV jabs. The following day, the Journal of the Royal Society of Medicine published a withering critique of Gardasil’s crooked clinical trials, “It is still uncertain whether human papillomavirus (HPV) vaccination prevents cervical cancer as trials were not designed to detect this outcome.”
As Gerberding knows, those trials revealed that Gardasil dramatically RAISES (by+44.6%) the risk of cervical cancer among women with a current infection or those previously exposed to HPV. That may explain the cancer explosions in England and other nations with high inoculation rates in young girls up to age 18; Australia, Spain, Sweden and Norway. A 2019 study of Alabama girls found the highest cervical cancer rates in the state’s most heavily vaccinated counties.
… Merck fraudulently concealed serious illnesses affecting half, and autoimmune diseases affecting 1 out of every 37 girls in Gardasil’s clinical trials within 6 months of injection
With Merck’s efficacy pretensions circling the drain, a coalition of leading plaintiff’s lawyers are already in discovery in a suit alleging that Merck fraudulently concealed serious illnesses affecting half, and autoimmune diseases affecting 1 of every 37 girls in Gardasil’s clinical trials within 6 months of injection.
As Centers for Disease Control (CDC) Director from 2002-2009, Gerberding helped Merck paper over these efficacy and safety problems. In 2006 she gave Merck the CDC recommendation that made Gardasil a $5 Billion blockbuster. Gerberding did other lucrative favors for Merck; blocking whistleblower Gary Goldman from disclosing that Merck’s chicken pox vaccine was causing a deadly shingles epidemic, silencing and punishing whistleblower Dr. William Thompson when he told her that CDC bigwigs were destroying data linking Merck’s MMR to autism, and allowing the company to illegally reformulate its MMR mumps component. Those courtesies earned her the Merck sinecure and stock options.
About the Author: Robert F. Kennedy, Jr.’s reputation as a resolute defender of the environment stems from a litany of successful legal actions. Mr. Kennedy was named one of Time magazine’s “Heroes for the Planet” for his success helping Riverkeeper lead the fight to restore the Hudson River. The group’s achievement helped spawn 300 Waterkeeper organizations across the globe.
Mr. Kennedy serves as Senior Attorney for the Natural Resources Defense Council, Chief Prosecuting Attorney for the Hudson Riverkeeper and President of Waterkeeper Alliance. He is also a Clinical Professor and Supervising Attorney at Pace University School of Law’s Environmental Litigation Clinic and is of counsel to Morgan & Morgan, a nationwide personal injury practice. He is co-host of Ring of Fire on Air America Radio. Earlier in his career he served as Assistant District Attorney in New York City.
He has worked on environmental issues across the Americas and has assisted several indigenous tribes in Latin America and Canada in successfully negotiating treaties protecting traditional homelands. He is credited with leading the fight to protect New York City’s water supply. The New York City watershed agreement, which he negotiated on behalf of environmentalists and New York City watershed consumers, is regarded as an international model in stakeholder consensus negotiations and sustainable development.
Mr. Kennedy is also a devout proponent for vaccine rights, the right to chose, informed consent, and the publication and public awareness of information needed by parents to make informed decisions for their much more vulnerable children. A large portion of his related works can be found on Childrens Health Defense.
The above article: Merck’s Vaccine Division President Julie Gerberding Sells $9.1 Million in Shares—Is She Jumping Ship? originated on Childrens Health Defense and is published here by contribution with attribution to the articles author Robert F. Kennedy, jr. and website childrenshealthdefense.org.
Read more articles by the Children’s Health Defense
TLB Editors Note: This is World Mercury Project on steroids! TLB highly recommends you click on the image below, visit this great website, and do whatever you can to help see this vital forum succeed … for the sake of our children !!!
Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. CHD is planning many strategies, including legal, in an effort to defend the health of our children and obtain justice for those already injured. Your support is essential to CHD’s successful mission.
Stay tuned to …
The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)
Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.
Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.